NANO MRNA Co.,Ltd. (TYO:4571)

NANO MRNA Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2010	FY 2009
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2010	Mar 31, 2009
Net Income	-832	-777	-1,308	-494.79	-524.48
Depreciation & Amortization	-	1	-	13.1	15.76
Other Amortization	-	-	-	3.18	-
Loss (Gain) From Sale of Assets	1	69	2	0.03	-1.63
Loss (Gain) From Sale of Investments	144	-42	228	-	-
Other Operating Activities	-3	1	43	0	-0
Change in Accounts Receivable	28	7	20	37.37	-42.96
Change in Inventory	-	-	32	-10.64	109.74
Change in Accounts Payable	-27	19	4	2.49	4.68
Change in Other Net Operating Assets	288	137	-108	-2.74	-17.71
Operating Cash Flow	-401	-585	-1,087	-452	-456.62
Capital Expenditures	-	-	-	-2.44	-2.97
Sale (Purchase) of Intangibles	-	-	-	-5.65	-1.5
Investment in Securities	492	878	1,204	-	-
Other Investing Activities	95	-85	3	0.02	0.47
Investing Cash Flow	587	793	1,207	-8.07	-4
Long-Term Debt Repaid	-568	-	-	-	-
Total Debt Repaid	-568	-	-	-	-
Net Debt Issued (Repaid)	-568	-	-	-	-
Issuance of Common Stock	-	3	-	97.37	74.99
Financing Cash Flow	-568	3	-	97.37	74.99
Foreign Exchange Rate Adjustments	4	54	59	-	-
Miscellaneous Cash Flow Adjustments	-	-	33	-	-
Net Cash Flow	-378	265	212	-362.69	-385.63
Free Cash Flow	-401	-585	-1,087	-454.43	-459.59
Free Cash Flow Margin	-371.30%	-433.33%	-538.12%	-385.70%	-129.96%
Free Cash Flow Per Share	-5.69	-8.32	-15.51	-35.59	-36.76
Cash Income Tax Paid	2	2	2	2.42	2.42
Levered Free Cash Flow	-225.88	-377	-	-228.59	-266.83
Unlevered Free Cash Flow	-225.88	-377	-	-228.59	-266.83
Change in Net Working Capital	-246	-162	-	-71.15	-54.27

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.